277
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of levetiracetam in premature infants: our experience and review of the literature

, , , , &
Pages 4093-4096 | Received 02 Jan 2017, Accepted 24 May 2018, Published online: 20 Jun 2018

References

  • Olson DM. Neonatal seizures. NeoReviews. 2012;13:e213–e223.
  • Thibeault-Eybalin MP, Lortie A, Carmant L. Neonatal seizures: do they damage the brain? Pediatr Neurol. 2009;40:175–180.
  • Ronen GM, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr. 1999;134:71–75.
  • Boylan GB, Rennie JM, Pressler RM, et al. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed. 2002;86:165–170.
  • Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia. 2001;42:24–27.
  • Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci. 2003;993:103–114.
  • Manthey D, Asimiadou S, Stefovska V, et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol. 2005;193:497–503.
  • Rakshasbhuvankar A, Rao S, Kohan R, et al. Intravenous levetiracetam for treatment of neonatal seizures. J Clin Neurosci. 2013;20:1165–1167.
  • Khan O, Chang E, Cipriani C, et al. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol. 2011;44:265–269.
  • Abend NS, Gutierrez-Colina AM, Monk HM, et al. Levetiracetam for treatment of neonatal seizures. J Child Neurol. 2011;26:465–470.
  • Shoemaker MT, Rotenberg JS. Levetiracetam for the treatment of neonatal seizures. J Child Neurol. 2007;22:95–98.
  • Fürwentsches A, Bussmann C, Ramantani G, et al. Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure. 2010;19:185–189.
  • Ramantani G, Ikonomidou C, Walter B, et al. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol. 2011;15:1–7.
  • Kirmani BF. Levetiracetam – an alternative option in preterm neonates for acute seizure management. Mol Cell Epilepsy. 2014;1:1–3.
  • Yau ML, Fung EL-W, Ng PC. Response of levetiracetam in neonatal seizures. WJCP. 2015;4:45–49.
  • Tulloch JK, Carr RR, Ensom MHH. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Pharmacol Ther. 2012;17:31–44.
  • Dahlin MG, Wide K, Ohman I. Age and comedications influence levetiracetam pharmacokinetics in children. Pediatr Neurol. 2010;43:231–235.
  • Sharpe CM, Capparelli EV, Mower A, et al. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Res. 2012;72:43–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.